Immuneering Corporation (IMRX)

NASDAQ: IMRX · Real-Time Price · USD

2.000

+0.160 (8.70%)

At close: Dec 20, 2024, 4:00 PM

1.950

-0.050 (-2.50%)

After-hours: Dec 20, 2024, 5:51 PM EST

Immuneering Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	45.21	59.41	72.64	74.89	37.09	13.78
Short-Term Investments	5.45	26.26	32.89	74.31	-	-
Cash & Short-Term Investments	50.66	85.67	105.52	149.2	37.09	13.78
Cash Growth	-47.91%	-18.82%	-29.27%	302.26%	169.12%	-
Receivables	-	-	0.01	0.25	0.5	0.21
Prepaid Expenses	4.6	3.42	3.21	2.89	0.14	0.07
Total Current Assets	55.26	89.08	108.75	152.33	37.73	14.06
Property, Plant & Equipment	4.95	5.4	5.78	6.13	0.68	0.04
Long-Term Investments	-	-	-	1	-	-
Goodwill	6.69	6.69	6.69	6.7	-	-
Other Intangible Assets	0.36	0.38	0.41	0.44	-	-
Other Long-Term Assets	1.3	1.03	0.74	0.1	0.01	-
Total Assets	68.56	102.58	122.37	166.7	38.42	14.1
Accounts Payable	1.94	2.11	3.15	1.39	1.48	0.29
Accrued Expenses	4.59	5.17	4.5	3.97	0.7	0.21
Current Portion of Leases	0.32	0.3	0.38	0.27	0.08	-
Other Current Liabilities	0.06	0.26	0.02	-	-	-
Total Current Liabilities	6.92	7.85	8.05	5.63	2.26	0.51
Long-Term Debt	-	-	-	-	-	3.51
Long-Term Leases	3.92	4.16	4.46	5.09	0.54	-
Total Liabilities	10.84	12.01	12.52	10.72	2.8	4.02
Common Stock	0.03	0.03	0.03	0.03	0	0
Additional Paid-In Capital	263.93	253.81	219.64	215.28	3.25	2.17
Retained Earnings	-206.24	-163.26	-109.79	-59.27	-25.74	-8.7
Comprehensive Income & Other	0.01	-0	-0.03	-0.05	-	-
Total Common Equity	57.72	90.58	109.85	155.98	-22.48	-6.53
Shareholders' Equity	57.72	90.58	109.85	155.98	35.62	10.08
Total Liabilities & Equity	68.56	102.58	122.37	166.7	38.42	14.1
Total Debt	4.24	4.46	4.84	5.36	0.62	3.51
Net Cash (Debt)	46.42	81.2	100.68	144.83	36.47	10.27
Net Cash Growth	-49.93%	-19.35%	-30.48%	297.13%	255.02%	-
Net Cash Per Share	1.57	2.86	3.82	10.64	7.37	2.08
Filing Date Shares Outstanding	31.05	29.28	26.44	26.38	4.95	4.95
Total Common Shares Outstanding	31.05	29.27	26.42	26.32	4.95	4.95
Working Capital	48.34	81.24	100.69	146.7	35.48	13.56
Book Value Per Share	1.86	3.09	4.16	5.93	-4.54	-1.32
Tangible Book Value	50.67	83.51	102.75	148.84	-22.48	-6.53
Tangible Book Value Per Share	1.63	2.85	3.89	5.65	-4.54	-1.32
Machinery	1.9	1.83	1.5	0.83	0.19	0.14
Leasehold Improvements	0.3	0.3	0.29	0.15	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.